Pfizer India site closure risks exacerbating cancer drug shortages
Pfizer has been forced to temporarily close a cancer drug factory in India. The factory won’t reopen for up to two years and is already contributing to cancer drug shortages. In July, heavy monsoon rain ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Cancer drug price caps: Why India needs more than price control indianexpress.com
